The partnership will integrate PhaseV's adaptive clinical trial technology with Alimentiv's comprehensive GI CRO services.

PhaseV, a pioneer in software and machine learning (ML) for clinical trial optimization, announced today it has entered a ...

Gastrointestinal-focused CRO Alimentiv is upgrading its clinical trials with software firm PhaseV’s adaptive trial technology ...

In early phase trials innovative designs offer potential for improvements in efficiency and decision-making. Determining the ...

According to leading data and analytics company GlobalData’s Clinical Trials Database, over the past 20 years trial activity ...

In this video interview, Michael Andreini, president and CEO of the Multiple Myeloma Research Foundation, highlights the ...

In this free webinar, learn about the trial design benefits and challenges presented by basket and umbrella trials. Attendees will gain insights into adaptive medical monitoring strategies crucial for ...

The US Food and Drug Administration has released draft guidance on protocol deviations, but experts say it could go further.

Inc. stock despite strong Phase 2b data. Click for my updated look at MNMD stock and its market opportunities.

MAIA Biotechnology, Inc., ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced positive updated data from its THIO-101 ...

India successfully tested three VSHORADS (Very Short-Range Air Defence System) missiles off the Odisha coast, marking a major ...

The World Health Organization (WHO) estimates that more than 1.5 billion people are affected by neglected tropical diseases (NTDs) and a further two billion are threatened by these diseases. If left ...